Kidney Cancer Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Understanding Biology With ADAPTeR Study
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses Understanding Biology With ADAPTeR Study. At The Fourteenth... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Sensitivity Of cfDNA Method
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses Sensitivity Of cfDNA Method. At The Fourteenth European Int... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Immune Signatures & Positioning Biopsy Needle
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses Immune Signatures & Positioning Biopsy Needle. At The Fourt... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Discussing The ADAPTeR Study
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses The ADAPTeR Study. At The Fourteenth European International... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Elaborating On Cell-Free DNA (cfDNA)
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses Elaborating On Cell-Free DNA (cfDNA). At The Fourteenth Eur... Author: kidneycancer Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Moving from Observational Pharmacoeconomics to Interventional Pharmacoeconomics
Daniel Goldstein MD Tel Aviv University discusses Moving from Observational Pharmacoeconomics to Interventional Pharmacoeconomics at the Kidney Cancer Association International Symposium 2019 in Dubro... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Spain: sogug model
Cristina Surez MD PhD Hospital Universitari Vall dHebron-Vall dHebron Institute of Oncology discusses SPAIN: SOGUG MODEL at the Kidney Cancer Association International Symposium 2019 in Dubrovnik,... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Centralization of Nephrectomy in the UK The good the bad and the ugly
Tim OBrien Vice President of BAUS discusses Centralization of Nephrectomy in the UK The good the bad and the ugly at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Brain Metastases in Renal Cell CarcinomaAre immune checkpoint inhibitors up to the task?
Ronan FlippotMD MSc discusses Brain Metastases in Renal Cell CarcinomaAre immune checkpoint inhibitors up to the task? discusses Brain Metastases in Renal Cell CarcinomaAre immune checkpoint inhi... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Recist vs iRecist: Clinically Significant?
Raquel Perez-Lopez Vall dHebron Institute of Oncology (VHIO) Principal Investigator-Radiomics Group discusses Recist vs iRecist: Clinically Significant? at the Kidney Cancer Association Internationa... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Nordic Registry Approach
Frede Donskov, M.D., DMSc Professor of Oncology Chairman, Kidney Cancer Expert Committee, Danish Medicines Council Aarhus University Hospital Denmark discusses the Nordic Registry Approach at the Kid... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Axi/Pembro is the Standard of Care in mRCC
Brian i. Rini, MD Cleveland Clinic discusses Axi/Pembro is the Standard of Care in mRCC at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

Part 2 - A phase II study of Anti-PD1 (nivolumab) therapy as pre- and post-operative therapy in metastatic renal cell cancer (ADAPTeR)
Samra Turajlic The Royal Marsden NHS Foundation Trust, London, UK discusses the second part of A phase II study of Anti-PD1 (nivolumab) therapy as pre- and post-operative therapy in metastatic renal c... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

New Network Around Oncologists
Dr Pablo Maroto Hospital Sant Pau Barcelona discusses New Network Around Oncologists at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts

IO toxicities in Kidney Cancer
Jean-Marie Michot, MD Drug Development Department Gustave Roussy, France jean-marie.michot@gustaveroussy.fr discusses IO toxicities in Kidney Cancer at the Kidney Cancer Association International Sym... Author: kidneycancer Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts